| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a14c99090d4b8a45d0c5bae727a8d370 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate |
2019-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b14fe4a70e741e9ecfbea1b80f3a059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3234ecc377efabeee67a77ffbd51942
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce167e3b3f267f9bacd611e40c6afa3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbf1c9a02a019fdfd8e66519cf192a61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea1d66a325d913f0ca7fe88fc8752d68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_126f1adca71d7e65124686eae51d57ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_967666c5e19ddb6bab92ac8f8a4fef01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78cea2ea38f156dab725fa347894b66a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c68d2e1c7f222974d847eb6529200da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a893ffde336dd5c4f85cfd53c0c661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d0a8f5477718fbb5a55c13d9208f576 |
| publicationDate |
2020-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110893240-A |
| titleOfInvention |
Application of NME2 gene in inhibiting avian reovirus replication |
| abstract |
The invention discloses application of an avian NME2 gene in inhibiting replication of avian reoviruses. The invention provides an application of NME2 gene or related biological materials thereof in preparing products for inhibiting the replication of avian reoviruses; the related biological material is an expression cassette containing the NME2 gene, a recombinant vector, a recombinant bacterium or a transgenic cell line or protein encoded by the NME2 gene. Experiments prove that the overexpression of the NME2 gene in DF1 cells and fluorescent quantitative PCR detection prove that the overexpression of the NME2 gene can inhibit the replication of ARV infection. The invention provides a new thought for preparing the biological preparation for clinically treating the ARV infection, and has important significance for the clinical treatment of the ARV. |
| priorityDate |
2019-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |